Biotech companies by one-year price change
How far the share price has moved over the last 52 weeks.
CRISPR Therapeutics has the lowest figure of the 24 biotech companies ranked by one-year price change, at -20.9%, followed by BioNTech (-16.3%) and argenx (+3.60%). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR Therapeutics-20.9%
- Median
- +40.0%
- Combined market value
- SGD 1.08T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | SGD 5.2B | SGD 53.45 | 3.25% up | 21% down | ||
| 2 | BioNTechBNTX · Health Care | -16.3% | SGD 26.8B | SGD 108.17 | 1.14% down | 16% down | ||
| 3 | argenxARGX · Health Care | +3.60% | SGD 76.8B | SGD 1,220.96 | 0.06% down | 4% up | ||
| 4 | RepligenRGEN · Health Care | +4.58% | SGD 14.3B | SGD 223.58 | 6.92% up | 5% up | ||
| 5 | QiagenQGEN · Health Care | +12.0% | SGD 13.2B | SGD 64.08 | 0.10% down | 12% up | ||
| 6 | Scholar Rock HoldingSRRK · Health Care | +13.6% | SGD 7.5B | SGD 61.34 | 5.52% up | 14% up | ||
| 7 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | SGD 21.4B | SGD 211.42 | 1.18% down | 20% up | ||
| 8 | VaxcytePCVX · Health Care | +22.2% | SGD 12B | SGD 75.71 | 1.15% down | 22% up | ||
| 9 | Bio-TechneTECH · Health Care | +25.6% | SGD 14.7B | SGD 93.87 | 0.23% up | 26% up | ||
| 10 | Gilead SciencesGILD · Health Care | +32.9% | SGD 270.3B | SGD 217.92 | 0.73% down | 33% up | ||
| 11 | AmgenAMGN · Health Care | +33.7% | SGD 311.3B | SGD 575.52 | 2.53% down | 34% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | +36.6% | SGD 14.2B | SGD 124.23 | 0.40% up | 37% up | ||
| 13 | ImmunovantIMVT · Health Care | +43.4% | SGD 8.9B | SGD 43.16 | 0.78% up | 43% up | ||
| 14 | Krystal BiotechKRYS · Health Care | +46.3% | SGD 12B | SGD 406.57 | 5.62% up | 46% up | ||
| 15 | BiogenBIIB · Health Care | +49.3% | SGD 48.1B | SGD 325.07 | 0.53% up | 49% up | ||
| 16 | ExelixisEXEL · Health Care | +62.6% | SGD 21.7B | SGD 88.99 | 0.76% up | 63% up | ||
| 17 | CG OncologyCGON · Health Care | +85.3% | SGD 9.2B | SGD 103.45 | 1.63% up | 85% up | ||
| 18 | Kymera TherapeuticsKYMR · Health Care | +87.5% | SGD 13.4B | SGD 157.43 | 0.48% up | 87% up | ||
| 19 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | SGD 6B | SGD 37.13 | 1.07% up | 88% up | ||
| 20 | Revolution MedicinesRVMD · Health Care | +131% | SGD 44.8B | SGD 207.04 | 1.30% down | 131% up | ||
| 21 | ImmunityBioIBRX · Health Care | +193% | SGD 9.2B | SGD 8.66 | 7.35% up | 193% up | ||
| 22 | Twist BioscienceTWST · Health Care | +340% | SGD 10.4B | SGD 152.68 | 5.72% up | 340% up | ||
| 23 | Kodiak SciencesKOD · Health Care | +396% | SGD 8.2B | SGD 124.71 | 0.08% down | 396% up | ||
| 24 | ModernaMRNA · Health Care | +755% | SGD 104.2B | SGD 257.53 | 3.42% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2894 SGD).
Questions and answers
Which biotech companies have the lowest one-year price change?
CRISPR Therapeutics (-20.9%), BioNTech (-16.3%) and argenx (+3.60%) have the lowest one-year price change of the 24 biotech companies ranked here as of 18 Nov 2026, 18:41 UTC.
How many biotech companies are in this ranking?
24 are ranked by one-year price change.
What are these biotech companies worth together?
The 24 biotech companies ranked by one-year price change have a combined market value of SGD 1.08T as of 18 Nov 2026, 18:41 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.